Compare SoundHound AI Inc (SOUN) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoundHound AI Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? SoundHound AI Inc trades at $5.4 (market cap $2.45B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.69 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 24× SoundHound AI Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold SoundHound AI Inc for 23 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| SOUN | TAK | |
|---|---|---|
Market Cap | $2.45B | $58.74B |
Volume | 16,881,989 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $21.40 | $19.05 |
52-Week Low | $5.52 | $13.23 |
Typical Hold Time | 23 Days | 0 Days |
Enterprise Value | $2.25B | $86.65B |
Dividend Yield | — | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SoundHound AI (SOUN) trades at $5.49, down 2.49% today, with bearish technical signals but strong analyst support. The company shows robust revenue growth with 2025 revenue of $168.92M and 2026 projected at $203M, though it remains unprofitable with a -67.45% net margin. Recent developments include expansion in restaurant and banking sectors with voice AI technology, while technical indicators show oversold conditions with RSI at 25-29.
The outlook remains speculative with significant execution risk despite 75% analyst buy ratings and a $9.33 consensus target. Key opportunities include voice AI market expansion and enterprise contract wins, while risks center on persistent losses, high valuation multiples, and competitive pressures in the AI sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
